Table 3.
Outcomes.
| (n = 49) | ||
|---|---|---|
| Primary outcome | ||
| All-cause mortality at 30 days | 38 | (78%) |
| Secondary endpoints at 30 days | ||
| MACCE | 40 | (82%) |
| AMI | 0 | (0%) |
| Revascularization | ||
| Staged PCI | 1 | (2.0%) |
| Staged CABG | 1 | (2.0%) |
| TLR | 2 | (4.1%) |
| Stroke | 1 | (2.0%) |
| Secondary outcomes at long-term follow-up | ||
| All-cause mortality | 42 | (86%) |
| MACCE | 46 | (94%) |
| AMI | 3 | (6.1%) |
| Revascularization | ||
| Any PCI | 2 | (4.1%) |
| Any CABG | 1 | (2.0%) |
| TLR | 2 | (4.1%) |
| Stroke | 2 | (4.1%) |
Values are n (%) or median (1st–3rd quartile). MACCE: major adverse cardiac and cerebrovascular events (defined as the composite of all-cause mortality, AMI, stroke and any revascularization); AMI: acute myocardial infarction; PCI: percutaneous coronary intervention; CABG: coronary artery bypass graft surgery; TLR: target lesion revascularization.